We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn the key differences between Basal Cell Carcinoma (BCC) and Melanoma, two common types of skin cancer. Understand their appearance, causes, risk factors, diagnosis, treatment, and prevention strategies.

Understanding Basal Cell Carcinoma and Melanoma: Key Differences in Skin Cancer Skin cancer is a prevalent health concern, and while often treatable, understanding the different types is crucial for early detection and effective management. Among the most common forms are Basal Cell Carcinoma (BCC) and Melanoma. Although both originate from skin cells and share some risk factors, they differ significantly in their appearance, growth patterns, treatment approaches, and prognosis. This article aims to clarify these distinctions, providing valuable information for Indian readers to better understand and identify these conditions. What are Basal Cell Carcinoma (BCC) and Melanoma? Basal Cell Carcinoma (BCC) is the most common type of skin cancer globally, including in India. It arises from the basal cells, which are found in the lower layer of the epidermis, the outermost layer of the skin. BCCs are typically slow-growing and rarely spread to other parts of the body. They often appear on sun-exposed areas like the face, ears, neck, and hands. Melanoma , while less common than BCC, is considered more dangerous because it has a higher tendency to spread (metastasize) to other organs if not detected and treated early. Melanoma develops from melanocytes, the cells responsible for producing melanin, the pigment that gives skin its colour. Melanomas can develop anywhere on the body, including areas not typically exposed to the sun, and can even arise from existing moles or appear as new, unusual spots. Appearance: How to Differentiate BCC and Melanoma Recognizing the visual differences between BCC and melanoma is a vital first step in seeking timely medical attention. While both can present as new growths or changes in existing moles, their characteristics often vary: Basal Cell Carcinoma (BCC) Appearance: Often appears as a pearly or waxy bump, sometimes flesh-coloured or brown/black. May look like a flat, scaly, or scar-like lesion. Can also present as a sore that bleeds and scabs over, then heals and recurs. Tiny blood vessels may be visible on the surface. Usually grows slowly and is painless. Melanoma Appearance: Melanomas are often identified using the ABCDE rule: A - Asymmetry: One half of the mole or spot does not match the other half. B - Border: The edges are irregular, ragged, notched, or blurred. C - Color: The colour is not uniform and may include shades of brown, black, pink, red, white, or blue. D - Diameter: Melanomas are typically larger than 6 millimetres (about the size of a pencil eraser), though they can be smaller. E - Evolving: The mole or spot changes in size, shape, colour, or elevation, or develops new symptoms like itching, tenderness, or bleeding. It is important to note that not all melanomas fit the ABCDE criteria, and some skin cancers may have features of both BCC and melanoma. Causes and Risk Factors The primary cause for both BCC and melanoma is long-term exposure to ultraviolet (UV) radiation. This exposure can come from: Sunlight: Prolonged and unprotected exposure to the sun is the leading cause. Tanning Beds and Sun Lamps: Artificial sources of UV radiation significantly increase risk. UV radiation damages the DNA in skin cells, leading to uncontrolled cell growth. Other significant risk factors include: Fair Skin: Individuals with lighter skin tones, who sunburn easily, are at higher risk. History of Sunburns: Especially blistering sunburns in childhood or adolescence. Numerous Moles: Having many moles, or atypical moles (dysplastic nevi), increases melanoma risk. Family History: A personal or family history of skin cancer. Weakened Immune System: Due to medical conditions or treatments. Age: Risk increases with age, though skin cancer can occur in younger individuals. Geographic Location: Living in areas with high levels of UV radiation. Diagnosis of BCC and Melanoma Diagnosing skin cancer typically involves a combination of visual examination and biopsy: Visual Examination: A dermatologist will examine your skin, looking for suspicious lesions. They may use a dermatoscope, a special magnifying tool, to get a closer look. Biopsy: If a lesion is suspicious, a small sample (biopsy) is taken and sent to a laboratory for microscopic examination. This is the definitive way to diagnose skin cancer and determine its type and stage. Treatment Options Treatment strategies for BCC and melanoma differ based on the type, size, location, and stage of the cancer. Treatment for Basal Cell Carcinoma (BCC): Since BCC rarely spreads, treatment primarily focuses on removing the cancerous growth. Common methods include: Surgical Excision: The tumor is cut out along with a margin of healthy skin. Mohs Surgery: A specialized technique where the tumor is removed layer by layer, with each layer examined under a microscope until no cancer cells remain. This is often used for BCCs in sensitive areas or those that are large or recurrent. Curettage and Electrodesiccation: The tumor is scraped away, and the base is cauterized with an electric needle. Cryosurgery: Freezing the tumor with liquid nitrogen. Topical Medications: Creams or ointments may be used for very superficial BCCs. Treatment for Melanoma: Melanoma treatment depends heavily on the stage: Early Stage Melanoma: Surgical excision is the primary treatment to remove the tumor and a surrounding margin of healthy tissue. The width of this margin depends on the thickness of the melanoma. Advanced or Metastatic Melanoma: If melanoma has spread to lymph nodes or other organs, more aggressive treatments are needed. These may include: Immunotherapy: Medications that boost the body's immune system to fight cancer cells. Targeted Therapy: Drugs that target specific genetic mutations
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026